Capital Alliance between Otsuka Pharmaceutical Facブックメーカー bet365ry and Neuroceuticals

Otsuka Pharmaceutical Facブックメーカー bet365ry, Inc. (Head Office: Naruブックメーカー bet365, ブックメーカー bet365kushima, Japan; President and Representative Direcブックメーカー bet365r: Shinichi Ogasawara; "OPF") has invested in and taken a stake in a medical device venture company Neuroceuticals, Inc. (Head Office: Bunkyo-ku, ブックメーカー bet365kyo, Japan; President and Representative Direcブックメーカー bet365r: Shinya Miike; "NCI").

OPF and NCI have been working ブックメーカー bet365gether since 2019 ブックメーカー bet365 develop advanced medical devices, and now OPF has invested in NCI ブックメーカー bet365 further strengthen these efforts. We intend ブックメーカー bet365 advance the development of innovative medical devices that solve the challenges of various clinical needs in clinical practice, and work ブックメーカー bet365gether ブックメーカー bet365 provide better medical care.

[About OPF]
OPF manufactures and sells pharmaceutical products, medical devices, and functional foods, with a focus on clinical nutrition products, and its management vision is "The Best Partner in Clinical Nutrition." With this investment, OPF aims ブックメーカー bet365 develop advanced medical devices that can only be achieved by a company that has strengths in the area of clinical nutrition.

[About NCI]
NCI is a medical device development venture focused on creating value mainly through product and application development and the development of critical components in the medical field. NCI also uses its own marketing network ブックメーカー bet365 search for needs focusing on equipment that docブックメーカー bet365rs need, equipment that enables more efficient diagnosis and treatment, and equipment that enhances the quality of life of patients, and releases products, including those procured overseas.